MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11102-025-01512-5

Медицинская библиотека · Pituitary · 2025

Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas.

Bostan Hayri, Ucan Bekir, Duger Hakan, Hepsen Sema, Kayihan Serdar, Dilli Alper, Ozturk Unsal Ilknur, Cakal Erman, Kizilgul Muhammed

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: The factors predicting the long-term response to cabergoline are not well known, particularly in more invasive prolactinomas. This study aimed to evaluate the rate of good response (GR) (normoprolactinemia and ≥ 50% tumor shrinkage) at the one-year follow-up and to identify predictors of GR in patients with large invasive prolactinomas.

METHODS

This retrospective single-center study included 38 patients (32 males, 6 females; mean age 41.9 ± 12.8 years) with invasive macroprolactinomas (baseline median prolactin: 2530 (1726-5451) ng/mL, mean longest tumor diameter: 36.4 ± 12.8 mm) who were followed for at least one year under cabergoline therapy. Prolactin levels and tumor volume changes were analyzed at early and late follow-ups. Patients were classified as good responders (GRs) or poor responders (PRs) based on their first-year outcomes.

RESULTS

At the first year, 17 patients (44.7%) achieved a GR. Baseline parameters were comparable between groups, but GRs had significantly higher normoprolactinemia rates (70.6% vs. 23.8%,p = 0.004) and greater tumor shrinkage (57.3 ± 15.6% vs. 41.9 ± 21.9%,p = 0.02) at 3-6 months. An early tumor shrinkage cut-off rate of 44.9% (88% sensitivity, 62% specificity) or an early prolactin cut-off level of 30 ng/mL (75% sensitivity, 77% specificity) were identified as good predictors of GR in the first-year. All GRs maintained normoprolactinemia and ≥ 50% tumor shrinkage, while 33.3% and 42.9% of PRs failed to meet these goals, respectively, at the last visit (p = 0.009, p = 0.002). Three of PRs required surgery during follow-up.

CONCLUSIONS

Approximately half of invasive prolactinoma patients achieved the composite goal within one year of cabergoline therapy. Early follow-up studies, rather than baseline characteristics, are strong predictors of treatment success.

Для цитирования: Bostan Hayri, Ucan Bekir, Duger Hakan, Hepsen Sema, Kayihan Serdar, Dilli Alper, Ozturk Unsal Ilknur, Cakal Erman, Kizilgul Muhammed. Good response rates and predictors during the first year of cabergoline treatment in large invasive prolactinomas.. Pituitary. 2025. DOI: 10.1007/s11102-025-01512-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.